Resveratrol and non-ethanolic components of wine in experimental cardiology.
The mechanisms through which the consumption of alcoholic beverages, in particular wine, protects against cardiac and vascular diseases remain largely unexplored. New methods are needed to investigate that crucial medical and scientific question. Several groups are now beginning to use animal models of myocardial ischemia and reperfusion to explore whether certain nutrients, including ethanol and non-ethanolic components of wine, may have a specific protective effect on the myocardium, independently from the classical risk factors involved in vascular atherosclerosis and thrombosis. Concepts used in experimental cardiology, such as preconditioning and stunning, are now entering the field of nutrition, and this will undoubtedly lead to considerable improvements in the prevention and treatment of cardiovascular diseases.
de Lorgeril
M
M
Laboratoire du Stress Cardiovasculaire et Pathologies Associées, Université Joseph Fourier, Grenoble, France. michel.delorgeril@ujf-grenoble.fr
Salen
P
P
Guiraud
A
A
Boucher
F
F
de Leiris
J
J
D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D006801:Humans; D000077185:Resveratrol; D013267:Stilbenes / Q000008:administration & dosage / Q000627:therapeutic use*; D014920:Wine
D000975:Antioxidants; D013267:Stilbenes; D000077185:Resveratrol